Satellos Bioscience Stock Forward View - Simple Moving Average
| MSCL Stock | 10.12 -0.93 -8.42% |
The forecast reference data for Satellos Bioscience on this page is generated using Simple Moving Average applied to historical price observations. Projected values and error measures are included as reference material.
The Simple Moving Average forecasted value of Satellos Bioscience on the next trading day is expected to be 10.12 with a mean absolute deviation of 0.65 and the sum of the absolute errors of 39.11.The simple moving average model is conceptually a linear regression of the current value of Satellos Bioscience price series against current and previous (unobserved) value of Satellos Bioscience. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future The Simple Moving Average reference values for Satellos Bioscience are derived from publicly available price data and should be used for informational purposes only. Simple Moving Average Price Forecast For the 22nd of March
Given 90 days horizon, the Simple Moving Average forecasted value of Satellos Bioscience on the next trading day is expected to be 10.12 with a mean absolute deviation of 0.65 , mean absolute percentage error of 0.78 , and the sum of the absolute errors of 39.11 .Please note that although there have been many attempts to predict Satellos Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Satellos Bioscience's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Satellos Bioscience | Satellos Bioscience Price Prediction | Research Analysis |
Forecasted Value
This next-day forecast for Satellos Bioscience uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. At the moment, the model places downside around 4.10 and upside around 16.14 for the forecasting period.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Satellos Bioscience stock data series using in forecasting. Note that when a statistical model is used to represent Satellos Bioscience stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.0245 |
| Bias | Arithmetic mean of the errors | -0.051 |
| MAD | Mean absolute deviation | 0.6518 |
| MAPE | Mean absolute percentage error | 0.0507 |
| SAE | Sum of the absolute errors | 39.11 |
Other Forecasting Options for Satellos Bioscience
Investors at all stages of experience who consider Satellos must develop an understanding of Satellos Bioscience's price dynamics. The noise embedded in Satellos Stock price charts can create misleading signals and skew investment decisions.Satellos Bioscience Related Equities
The following equities are related to Satellos Bioscience within the Biotechnology space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Satellos Bioscience against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Satellos Bioscience Market Strength Events
Market strength indicators applied to Satellos Bioscience stock give investors a structured view of the security's momentum relative to the overall market. Using these indicators, traders can refine their timing when entering or exiting positions in Satellos Bioscience.
Satellos Bioscience Risk Indicators
Evaluating Satellos Bioscience's risk indicators is an important step in accurately forecasting its price and assessing the suitability of an investment. Understanding the risk profile of Satellos Bioscience's allows investors to make more informed decisions about position sizing and risk.
| Mean Deviation | 4.36 | |||
| Semi Deviation | 5.84 | |||
| Standard Deviation | 5.81 | |||
| Variance | 33.76 | |||
| Downside Variance | 39.75 | |||
| Semi Variance | 34.06 | |||
| Expected Short fall | -4.65 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Satellos Bioscience
The amount of media and story coverage tied to Satellos Bioscience can signal where market attention is concentrating at the moment. A disciplined read of coverage separates durable relevance from temporary noise.
Other Macroaxis Stories
Macroaxis publishes story content for a diverse readership that includes finance students, independent investors, money managers, and market-focused operating teams. What connects that audience is a focus on building stronger portfolios through better research, risk awareness, and comparative analysis.
Story Categories
Currently Trending Categories
Satellos Bioscience Short Properties
Short sentiment tied to Satellos Bioscience matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 9.6 M | |
| Cash And Short Term Investments | 69.9 M |
More Resources for Satellos Stock Analysis
Other Information on Investing in Satellos Stock
Satellos Bioscience ratios capture relationships across its reported financial data. They outline how earnings and cash flow connect to company value. This approach standardizes how financial data is compared. This information is derived from the most recent year, quarter, or monthly reporting available.